<?xml version="1.0"?>
<feed xmlns="http://www.w3.org/2005/Atom" xml:lang="ro">
	<id>https://wiki.tradeville.ro/index.php?action=history&amp;feed=atom&amp;title=DENALI_THERAPEUTICS_INC</id>
	<title>DENALI THERAPEUTICS INC - Revizia istoricului</title>
	<link rel="self" type="application/atom+xml" href="https://wiki.tradeville.ro/index.php?action=history&amp;feed=atom&amp;title=DENALI_THERAPEUTICS_INC"/>
	<link rel="alternate" type="text/html" href="https://wiki.tradeville.ro/index.php?title=DENALI_THERAPEUTICS_INC&amp;action=history"/>
	<updated>2026-05-20T08:15:35Z</updated>
	<subtitle>Istoricul versiunilor pentru această pagină din wiki</subtitle>
	<generator>MediaWiki 1.39.2</generator>
	<entry>
		<id>https://wiki.tradeville.ro/index.php?title=DENALI_THERAPEUTICS_INC&amp;diff=416461&amp;oldid=prev</id>
		<title>Admin: Pagină nouă: Pagina dedicata companiei DENALI THERAPEUTICS INC listata cu simbolul US.DNLI  ==Descriere companie== Denali Therapeutics Inc. (https://www.denalitherapeutics.com)is a biopharmaceutical company. The Company is focused on the discovery and development of therapies for patients with neurodegenerative diseases, including Alzheimer's disease, Parkinson's disease, amyotrophic lateral sclerosis (ALS) and others. The Company clinical programs include leucine-rich repeat kinase 2 (LR...</title>
		<link rel="alternate" type="text/html" href="https://wiki.tradeville.ro/index.php?title=DENALI_THERAPEUTICS_INC&amp;diff=416461&amp;oldid=prev"/>
		<updated>2024-09-18T17:50:49Z</updated>

		<summary type="html">&lt;p&gt;Pagină nouă: Pagina dedicata companiei DENALI THERAPEUTICS INC listata cu simbolul US.DNLI  ==Descriere companie== Denali Therapeutics Inc. (https://www.denalitherapeutics.com)is a biopharmaceutical company. The Company is focused on the discovery and development of therapies for patients with neurodegenerative diseases, including Alzheimer&amp;#039;s disease, Parkinson&amp;#039;s disease, amyotrophic lateral sclerosis (ALS) and others. The Company clinical programs include leucine-rich repeat kinase 2 (LR...&lt;/p&gt;
&lt;p&gt;&lt;b&gt;Pagină nouă&lt;/b&gt;&lt;/p&gt;&lt;div&gt;Pagina dedicata companiei DENALI THERAPEUTICS INC listata cu simbolul US.DNLI&lt;br /&gt;
&lt;br /&gt;
==Descriere companie==&lt;br /&gt;
Denali Therapeutics Inc. (https://www.denalitherapeutics.com)is a biopharmaceutical company. The Company is focused on the discovery and development of therapies for patients with neurodegenerative diseases, including Alzheimer's disease, Parkinson's disease, amyotrophic lateral sclerosis (ALS) and others. The Company clinical programs include leucine-rich repeat kinase 2 (LRRK2) inhibitor program, eukaryotic initiation factor 2 B (EIF2B) activator program, enzyme transport vehicle: iduronate 2-sulfatase (ETV:IDS) program, receptor interacting serine/threonine protein kinase 1 (RIPK1) inhibitor program and second non-CNS penetrant RIPK1 inhibitor. The Company engineers its product candidates to cross the blood-brain barrier (BBB), and act directly in the brain. Its pipeline includes approximately 15 programs that are based on its TV technology, including the lead program ETV:IDS (DNL310). Its product pipeline includes DNL151, DNL593 (PTV:PGRN), DNL126 (ETV:SGSH), DNL788, DNL343, DNL758.&lt;br /&gt;
&lt;br /&gt;
==Grafic actiuni companie==&lt;br /&gt;
&amp;lt;iframe key=&amp;quot;tradeville&amp;quot; path=&amp;quot;graficSimbol/US.DNLI&amp;quot; /&amp;gt;&lt;br /&gt;
&lt;br /&gt;
==Ultimele stiri despre DENALI THERAPEUTICS INC (US.DNLI)==&lt;br /&gt;
&amp;lt;dynamicpagelist&amp;gt;&lt;br /&gt;
category=US.DNLI&lt;br /&gt;
count=10&lt;br /&gt;
order=descending&lt;br /&gt;
addfirstcategorydate=false&lt;br /&gt;
&amp;lt;/dynamicpagelist&amp;gt;&lt;br /&gt;
&lt;br /&gt;
[[Categorie:US.DNLI]][[Categorie:Stiri despre companii]]&lt;/div&gt;</summary>
		<author><name>Admin</name></author>
	</entry>
</feed>